Literature DB >> 19187096

Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction.

Swetha K Godavarthi1, Doronala Narender, Amit Mishra, Anand Goswami, Sudheendra N R Rao, Nobuyuki Nukina, Nihar Ranjan Jana.   

Abstract

Huntington's disease is a hereditary neurodegenerative disorder caused by an aberrant polyglutamine expansion in the amino terminus of the huntingtin protein. The resultant mutant huntingtin form aggregates in neurons and causes neuronal dysfunction and degeneration in many ways including transcriptional dysregulation. Here, we report that the expression of mutant huntingtin in the mouse neuroblastoma cell results in massive transcriptional induction of several chemokines including monocyte chemoattractant protein-1 (MCP-1) and murine chemokine (KC). The mutant huntingtin expressing cells also exhibit proteasomal dysfunction and down-regulation of NF-kappaB activity in a time-dependent manner and both these phenomena regulate the expression of MCP-1 and KC. The expression of MCP-1 and KC are increased in the mutant huntingtin expressing cells in response to mild proteasome inhibition. However, the expression of MCP-1 and KC and proteasome activity are not altered and inflammation is rarely observed in the brain of 12-week-old Huntington's disease transgenic mice in comparison with their age-matched controls. Our result suggests that the mutant huntingtin-induced proteasomal dysfunction can up-regulate the expression of MCP-1 and KC in the neuronal cells and therefore might trigger the inflammation process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187096     DOI: 10.1111/j.1471-4159.2008.05823.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  Abnormal peripheral chemokine profile in Huntington's disease.

Authors:  Edward Wild; Anna Magnusson; Nayana Lahiri; Ulrika Krus; Michael Orth; Sarah J Tabrizi; Maria Björkqvist
Journal:  PLoS Curr       Date:  2011-04-13

2.  Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.

Authors:  Jayeeta Ghose; Mithun Sinha; Eashita Das; Nihar R Jana; Nitai P Bhattacharyya
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

Review 3.  The role of the immune system in triplet repeat expansion diseases.

Authors:  Marta Olejniczak; Martyna O Urbanek; Wlodzimierz J Krzyzosiak
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

Review 4.  Immunotherapies in Huntington's disease and α-Synucleinopathies.

Authors:  Oluwaseun Fatoba; Yosuke Ohtake; Takahide Itokazu; Toshihide Yamashita
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

5.  AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's disease.

Authors:  Laura Taylor Alto; Xi Chen; Kelly A Ruhn; Isaac Treviño; Malú G Tansey
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.